https://www.thebodypro.com/category/hiv-epidemiology/tag/conference-coverage
HIV Epidemiology

Conference Coverage

The Latest

CDC campus

Black Gay Men Reject 'Lifetime HIV Risk Estimate' in New CDC Report

This widely reported study presented by the U.S. CDC at CROI 2016 is stirring conversation and outright rejection among many black gay men, reports Darian Aaron.

Lifetime Risk of HIV Diagnosis: Half of Black Gay Men and a Quarter of Latino Gay Men Projected to Be Diagnosed Within Their Lifetime Img

Lifetime Risk of HIV Diagnosis: Half of Black Gay Men and a Quarter of Latino Gay Men Projected to Be Diagnosed Within Their Lifetime

"Hundreds of thousands of people will be diagnosed in their lifetime if we don't scale up efforts now," said the CDC's Jonathan Mermin, M.D., at CROI 2016.

What Are the Odds You'll Get HIV in Your Lifetime? A New CDC Study Breaks It Down Img

What Are the Odds You'll Get HIV in Your Lifetime? A New CDC Study Breaks It Down

New numbers cast into sharp relief the extent to which U.S. HIV rates differ by race, sex and state. They range from a stunningly high lifetime risk of 1 in 2 for black men who have sex with men, to a relatively low risk of 1 in 883 for Asian women....

Women and HIV: Same Treatment, Different Care Img

Women and HIV: Same Treatment, Different Care

Women with HIV should receive not only the same antiretroviral therapy as men, but also clinical care tailored to their specific risk factors and health care goals, according to Kathleen Squires, M.D.

Sex Workers, Injection Drug Users and Men Who Have Sex With Men Continue to Be Most Affected by HIV Epidemic, Panelists Say Img

Sex Workers, Injection Drug Users and Men Who Have Sex With Men Continue to Be Most Affected by HIV Epidemic, Panelists Say

People involved in sex work are 12 times more likely, men who have sex with men are 19 times more likely, and people who inject drugs are 28 times more likely to become infected with HIV than the general public.

WAVES Study Shows HIV Treatment Efficacy Differs Between Women and Men Img

WAVES Study Shows HIV Treatment Efficacy Differs Between Women and Men

An all-female group of patients might respond slightly differently to HIV treatment regimens than a mostly male population, according to the Women AntiretroViral Efficacy and Safety (WAVES) study.

Roy Gulick on the Evolution of HIV Treatment After 1996 (Video) Img

Roy Gulick on the Evolution of HIV Treatment After 1996 (Video)

Today, new classes of antiretrovirals, such as attachment inhibitors, continue to be developed, and synthetic versions of naturally occurring antibodies -- broadly neutralizing antibodies -- are being studied for both HIV treatment and prevention....

Julio Montaner on the Last 20 Years in HIV Research (Video) Img

Julio Montaner on the Last 20 Years in HIV Research (Video)

Looking back on how far we have come, Julio Montaner, M.D., director of the British Columbia Centre for Excellence in HIV/AIDS says we now have the "irrefutable, conclusive, impeccable" proof that starting HIV treatment immediately after testing posi...

Large Variation Across Countries in Meeting UNAIDS 90-90-90 Targets Img

Large Variation Across Countries in Meeting UNAIDS 90-90-90 Targets

Analysis of national treatment cascades showed huge variation in achieving UNAIDS 90-90-90 targets. The proportion of HIV positive people with undetectable viral load ranged from 68% in Switzerland to 9% in Russia. No country analysed met the UNAIDS ...

HIV Remission for More Than 12 Years After Very Early Treatment in French Teenager Img

HIV Remission for More Than 12 Years After Very Early Treatment in French Teenager

An 18-year-old female has been able to maintain an undetectable viral load for more than 12 years after interrupting early antiretroviral treatment, according to a study presented at IAS 2015.